These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2264573)

  • 1. Chronic therapy for congestive heart failure with benazepril HCl, a new angiotensin converting enzyme inhibitor.
    Mirvis DM; Insel J; Boland MJ; Cinquegrani MP; Ghali JK; Rubin SA; Shanes J; DeSilva J; Whalen JJ
    Am J Med Sci; 1990 Dec; 300(6):354-60. PubMed ID: 2264573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure.
    Insel J; Mirvis DM; Boland MJ; Cinquegrani MP; Shanes J; Rubin SA; Whalen JJ
    Clin Pharmacol Ther; 1989 Mar; 45(3):312-20. PubMed ID: 2537699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term therapy with benazepril in patients with congestive heart failure: effects on clinical status and exercise tolerance.
    Ribner HS; Sagar KB; Glasser SP; Hsieh AM; Dills CV; Larkin S; DeSilva J; Whalen JJ
    J Clin Pharmacol; 1990 Dec; 30(12):1106-11. PubMed ID: 2273083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The Benazepril Heart Failure Study Group.
    Colfer HT; Ribner HS; Gradman A; Hughes CV; Kapoor A; Laidlaw JC
    Am J Cardiol; 1992 Aug; 70(3):354-8. PubMed ID: 1632402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure.
    Mitrovic V; Mudra H; Bonzel T; Schmidt W; Strand JC; Bakovic-Alt R; Posvar EL
    Clin Pharmacol Ther; 1996 Jun; 59(6):686-98. PubMed ID: 8681494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure.
    Grassi G; Cattaneo BM; Seravalle G; Lanfranchi A; Pozzi M; Morganti A; Carugo S; Mancia G
    Circulation; 1997 Aug; 96(4):1173-9. PubMed ID: 9286946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and renal effects of a new angiotensin converting enzyme inhibitor, benazepril, in essential hypertension.
    Valvo E; Casagrande P; Bedogna V; Antiga L; Alberti D; Zamboni M; Perobelli L; Dal Santo F; Maschio G
    J Hypertens; 1990 Nov; 8(11):991-5. PubMed ID: 1963190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure.
    Balfour JA; Goa KL
    Drugs; 1991 Sep; 42(3):511-39. PubMed ID: 1720384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.
    Woie L; Dickstein K; Kaada B
    Gen Pharmacol; 1987; 18(6):577-87. PubMed ID: 2822521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensinergic versus nonangiotensinergic hemodynamic effects of converting enzyme inhibition in patients with chronic heart failure. Assessment by acute renin and converting enzyme inhibition.
    Kiowski W; Beermann J; Rickenbacher P; Haemmerli R; Thomas M; Burkart F; Meinertz T
    Circulation; 1994 Dec; 90(6):2748-56. PubMed ID: 7994817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure.
    Dickstein K; Aarsland T; Woie L; Abrahamsen AM; Fyhrquist F; Cummings S; Gomex HJ; Hagen E; Kristianson K
    Am Heart J; 1986 Jul; 112(1):121-9. PubMed ID: 3014850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
    Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M
    Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.
    Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH
    N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure.
    Cody RJ; Covit AB; Schaer GL; Laragh JH
    J Am Coll Cardiol; 1983 Apr; 1(4):1154-9. PubMed ID: 6187789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hemodynamics effects of ACE inhibitors in the treatment of congestive heart failure.
    Nieminen MS; Kupari M
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S36-40. PubMed ID: 1691405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of salt balance on the renal and hemodynamic actions of benazepril in normal men.
    Noormohamed FH; Fuller GN; Lant AF
    J Clin Pharmacol; 1989 Oct; 29(10):928-37. PubMed ID: 2687336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.